139 related articles for article (PubMed ID: 33227346)
1. Particle properties and drug metastable solubility of simvastatin containing PVP matrix particles prepared by electrospraying technique.
Sterle Zorec B; Zupančič Š; Lavrič Z; Dreu R
Eur J Pharm Sci; 2021 Mar; 158():105649. PubMed ID: 33227346
[TBL] [Abstract][Full Text] [Related]
2. A bird's eye view of nanoparticles prepared by electrospraying: advancements in drug delivery field.
Pawar A; Thakkar S; Misra M
J Control Release; 2018 Sep; 286():179-200. PubMed ID: 30053427
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration.
Nath SD; Son S; Sadiasa A; Min YK; Lee BT
Int J Pharm; 2013 Feb; 443(1-2):87-94. PubMed ID: 23291448
[TBL] [Abstract][Full Text] [Related]
4. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
[TBL] [Abstract][Full Text] [Related]
5. Amorphous solid dispersions of ketoprofen and poly-vinyl polymers prepared via electrospraying and spray drying: A comparison of particle characteristics and performance.
Browne E; Charifou R; Worku ZA; Babu RP; Healy AM
Int J Pharm; 2019 Jul; 566():173-184. PubMed ID: 31132449
[TBL] [Abstract][Full Text] [Related]
6. Electrospraying as a novel method of particle engineering for drug delivery vehicles.
Tanhaei A; Mohammadi M; Hamishehkar H; Hamblin MR
J Control Release; 2021 Feb; 330():851-865. PubMed ID: 33137365
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical Applications of Electrospraying.
Nguyen DN; Clasen C; Van den Mooter G
J Pharm Sci; 2016 Sep; 105(9):2601-2620. PubMed ID: 27287515
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Physicochemical Characterisation and DoE Optimisation of a Spray-Dried Dry Emulsion Platform for Delivery of a Poorly Soluble Drug, Simvastatin.
Pohlen M; Lavrič Z; Prestidge C; Dreu R
AAPS PharmSciTech; 2020 Apr; 21(4):119. PubMed ID: 32318974
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of the Amorphous Structure of Spray-Dried Drug Nanoparticles.
Amstad E; Spaepen F; Weitz DA
J Phys Chem B; 2016 Sep; 120(34):9161-5. PubMed ID: 27441485
[TBL] [Abstract][Full Text] [Related]
10. Gallic Acid-Loaded Zein Nanoparticles by Electrospraying Process.
Tapia-Hernández JA; Del-Toro-Sánchez CL; Cinco-Moroyoqui FJ; Ruiz-Cruz S; Juárez J; Castro-Enríquez DD; Barreras-Urbina CG; López-Ahumada GA; Rodríguez-Félix F
J Food Sci; 2019 Apr; 84(4):818-831. PubMed ID: 30802954
[TBL] [Abstract][Full Text] [Related]
11. Amorphous solid dispersions of darunavir: Comparison between spray drying and electrospraying.
Smeets A; Koekoekx R; Clasen C; Van den Mooter G
Eur J Pharm Biopharm; 2018 Sep; 130():96-107. PubMed ID: 29928980
[TBL] [Abstract][Full Text] [Related]
12. A redispersible dry emulsion system with simvastatin prepared via fluid bed layering as a means of dissolution enhancement of a lipophilic drug.
Pohlen M; Pirker L; Luštrik M; Dreu R
Int J Pharm; 2018 Oct; 549(1-2):325-334. PubMed ID: 30075251
[TBL] [Abstract][Full Text] [Related]
13. One-step production of darunavir solid dispersion nanoparticles coated with enteric polymers using electrospraying.
Nguyen DN; Palangetic L; Clasen C; Van den Mooter G
J Pharm Pharmacol; 2016 May; 68(5):625-33. PubMed ID: 26272245
[TBL] [Abstract][Full Text] [Related]
14. The potential of nanofibers to increase solubility and dissolution rate of the poorly soluble and chemically unstable drug lovastatin.
Kajdič S; Zupančič Š; Roškar R; Kocbek P
Int J Pharm; 2020 Jan; 573():118809. PubMed ID: 31678525
[TBL] [Abstract][Full Text] [Related]
15. Influence of solvent mixtures on HPMCAS-celecoxib microparticles prepared by electrospraying.
Bohr A; Wang Y; Beck-Broichsitter M; Yang M
Asian J Pharm Sci; 2018 Nov; 13(6):584-591. PubMed ID: 32104432
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
17. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics.
Ahmed OA; Hosny KM; Al-Sawahli MM; Fahmy UA
Drug Des Devel Ther; 2015; 9():655-62. PubMed ID: 25670883
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
[TBL] [Abstract][Full Text] [Related]
19. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
20. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
